Legal Disclaimer
This page provides general legal orientation for North Carolina, not legal advice. Peptide regulations change frequently. Always verify current statutes with your state pharmacy board and consult a licensed attorney for specific legal guidance.
Peptide Legal Status in North Carolina
Standard federal compliance with typical state oversight. North Carolina follows federal compounding guidelines with standard pharmacy board oversight. The state has a growing wellness industry but maintains standard regulatory oversight.
Want provider rollout updates for North Carolina?
We are expanding country-aware provider workflows beyond the US. Join the rollout list for North Carolina-adjacent legal and provider guidance.
Join provider rolloutKey Facts
North Carolina Regulatory Details
Peptide Availability in North Carolina
| Peptide | FDA Status | Evidence | Availability |
|---|---|---|---|
| BPC-157 | Not Approved | C | Standard Access |
| TB-500 (Thymosin Beta-4) | Not Approved | C | Standard Access |
| GHK-Cu | Not Approved | B | Standard Access |
| Ipamorelin | Not Approved | B | Standard Access |
| CJC-1295 | Not Approved | B | Standard Access |
| Sermorelin | Approved | A | Available by Rx |
| Tesamorelin | Approved | A | Available by Rx |
| Bremelanotide (PT-141) | Approved | A | Available by Rx |
| Semaglutide | Approved | A | Available by Rx |
| Tirzepatide | Approved | A | Available by Rx |
| AOD-9604 | Not Approved | C | Standard Access |
| DSIP (Delta Sleep-Inducing Peptide) | Not Approved | D | Standard Access |
| Epithalon (Epitalon) | Not Approved | C | Standard Access |
| Selank | Not Approved | B | Standard Access |
| Semax | Not Approved | B | Standard Access |
| GHRP-2 | Not Approved | B | Standard Access |
| GHRP-6 | Not Approved | B | Standard Access |
| Hexarelin | Not Approved | B | Standard Access |
| Melanotan II | Not Approved | C | Standard Access |
| LL-37 | Not Approved | C | Standard Access |
| Thymalin | Not Approved | C | Standard Access |
| KPV | Not Approved | D | Standard Access |
| Liraglutide | Approved | A | Available by Rx |
| Retatrutide | Not Approved | B | Standard Access |
| Exenatide | Approved | A | Available by Rx |
| Dulaglutide | Approved | A | Available by Rx |
| Teriparatide | Approved | A | Available by Rx |
| Octreotide | Approved | A | Available by Rx |
| Triptorelin | Approved | A | Available by Rx |
| Desmopressin | Approved | A | Available by Rx |
| Setmelanotide | Approved | A | Available by Rx |
| Pramlintide | Not Approved | A | Standard Access |
| Survodutide | Not Approved | B | Standard Access |
| Linaclotide | Approved | A | Available by Rx |
| Plecanatide | Approved | A | Available by Rx |
| Teduglutide | Approved | A | Available by Rx |
| Abaloparatide | Approved | A | Available by Rx |
| Lanreotide | Approved | A | Available by Rx |
| Ziconotide | Approved | A | Available by Rx |
| Vosoritide | Approved | A | Available by Rx |
| SS-31 (Elamipretide) | Not Approved | B | Standard Access |
| MOTS-c | Not Approved | C | Standard Access |
| Humanin | Not Approved | C | Standard Access |
| FOXO4-DRI | Not Approved | D | Standard Access |
| Cerebrolysin | Not Approved | B | Standard Access |
| Oxytocin | Approved | A | Available by Rx |
| Dihexa | Not Approved | D | Standard Access |
| IGF-1 LR3 | Not Approved | D | Standard Access |
| Follistatin-344 | Not Approved | D | Standard Access |
| MGF (Mechano Growth Factor) | Not Approved | D | Standard Access |
| P21 | Not Approved | D | Standard Access |
| Kisspeptin-10 | Not Approved | B | Standard Access |
| Gonadorelin (GnRH) | Approved | A | Available by Rx |
| ARA-290 (Cibinetide) | Not Approved | B | Standard Access |
| Adamax | Not Approved | D | Standard Access |
| Pinealon | Not Approved | C | Standard Access |
| Tesofensine | Not Approved | A | Standard Access |
Peptides in North Carolina: FAQ
Medical Disclaimer
This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations.
Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Do not disregard professional medical advice based on information found on this site.
No claims of therapeutic efficacy are made for substances that are not FDA-approved for the discussed indications. Research citations reflect published findings and do not imply endorsement.